Identifying possible homozygous familial hypercholesterolemia patients : an Italian experts' opinion
Homozygous familial hypercholesterolemia (HoFH) is a rare genetic disease characterized by high plasma levels of low-density lipoprotein cholesterol (LDL-C) and massive risk of premature atheromasia and cardiovascular events. HoFH is caused by mutations in several genes, such as LDLR, APOB, PCSK9 and LDLRAP1. If untreated, the average age of death is 18 years old, but fatalities within the first 5 years of age have been recorded. Therefore, early diagnosis and treatment are crucial, in order to prevent and/or delay the cardiovascular complications of LDL-C exposure. Because HoFH is a rare disorder, it is not frequently encountered in daily clinical practice at the primary/secondary unspecialized cardiological centers. Then the availability of practical indications helping to identify HoFH patients or to arise a suspect of HoFH is particularly strategic to promptly start the appropriate lipid-lowering therapy. For such a purpose, a group of Italian experts suggests three useful algorithms to identify cases requiring accurate and specialized clinical evaluation as potential HoFH patients. These cases with suspected HoFH should be addressed to specialized centres for the optimal management of these patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
Giornale italiano di cardiologia (2006) - 24(2023), 1 vom: 17. Jan., Seite 5-10 |
| Sprache: |
Italienisch |
|---|
| Weiterer Titel: |
Inquadramento diagnostico del paziente con possibile ipercolesterolemia familiare omozigote: il parere di un gruppo italiano di esperti |
|---|
| Beteiligte Personen: |
Bilato, Claudio [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anticholesteremic Agents |
|---|
| Anmerkungen: |
Date Completed 28.12.2022 Date Revised 15.03.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1714/3934.39174 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM350849870 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM350849870 | ||
| 003 | DE-627 | ||
| 005 | 20231226045925.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||ita c | ||
| 024 | 7 | |a 10.1714/3934.39174 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1169.xml |
| 035 | |a (DE-627)NLM350849870 | ||
| 035 | |a (NLM)36573504 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ita | ||
| 100 | 1 | |a Bilato, Claudio |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Identifying possible homozygous familial hypercholesterolemia patients |b an Italian experts' opinion |
| 246 | 3 | 3 | |a Inquadramento diagnostico del paziente con possibile ipercolesterolemia familiare omozigote: il parere di un gruppo italiano di esperti |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.12.2022 | ||
| 500 | |a Date Revised 15.03.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Homozygous familial hypercholesterolemia (HoFH) is a rare genetic disease characterized by high plasma levels of low-density lipoprotein cholesterol (LDL-C) and massive risk of premature atheromasia and cardiovascular events. HoFH is caused by mutations in several genes, such as LDLR, APOB, PCSK9 and LDLRAP1. If untreated, the average age of death is 18 years old, but fatalities within the first 5 years of age have been recorded. Therefore, early diagnosis and treatment are crucial, in order to prevent and/or delay the cardiovascular complications of LDL-C exposure. Because HoFH is a rare disorder, it is not frequently encountered in daily clinical practice at the primary/secondary unspecialized cardiological centers. Then the availability of practical indications helping to identify HoFH patients or to arise a suspect of HoFH is particularly strategic to promptly start the appropriate lipid-lowering therapy. For such a purpose, a group of Italian experts suggests three useful algorithms to identify cases requiring accurate and specialized clinical evaluation as potential HoFH patients. These cases with suspected HoFH should be addressed to specialized centres for the optimal management of these patients | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Cholesterol, LDL |2 NLM | |
| 650 | 7 | |a PCSK9 protein, human |2 NLM | |
| 650 | 7 | |a EC 3.4.21.- |2 NLM | |
| 650 | 7 | |a Proprotein Convertase 9 |2 NLM | |
| 650 | 7 | |a EC 3.4.21.- |2 NLM | |
| 650 | 7 | |a Anticholesteremic Agents |2 NLM | |
| 700 | 1 | |a Zambon, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Pisciotta, Livia |e verfasserin |4 aut | |
| 700 | 1 | |a Citroni, Nadia |e verfasserin |4 aut | |
| 700 | 1 | |a Carubbi, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Zambon, Sabina |e verfasserin |4 aut | |
| 700 | 1 | |a Zenti, Maria Grazia |e verfasserin |4 aut | |
| 700 | 1 | |a Vinci, Pierandrea |e verfasserin |4 aut | |
| 700 | 1 | |a Biolo, Gianni |e verfasserin |4 aut | |
| 700 | 1 | |a Bonomo, Katia |e verfasserin |4 aut | |
| 700 | 1 | |a Egalini, Filippo |e verfasserin |4 aut | |
| 700 | 1 | |a Passaro, Angelina |e verfasserin |4 aut | |
| 700 | 1 | |a Nascimbeni, Fabio |e verfasserin |4 aut | |
| 700 | 1 | |a Negri, Emanuele |e verfasserin |4 aut | |
| 700 | 1 | |a D'Addato, Sergio |e verfasserin |4 aut | |
| 700 | 1 | |a Averna, Maurizio |e verfasserin |4 aut | |
| 700 | 1 | |a Arca, Marcello |e verfasserin |4 aut | |
| 700 | 1 | |a Oliva, Fabrizio |e verfasserin |4 aut | |
| 700 | 1 | |a Colivicchi, Furio |e verfasserin |4 aut | |
| 700 | 1 | |a Catapano, Alberico |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Giornale italiano di cardiologia (2006) |d 2006 |g 24(2023), 1 vom: 17. Jan., Seite 5-10 |w (DE-627)NLM16119561X |x 1972-6481 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2023 |g number:1 |g day:17 |g month:01 |g pages:5-10 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1714/3934.39174 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2023 |e 1 |b 17 |c 01 |h 5-10 | ||